Healthcare Market Research Panels: Reaching Doctors, Patients and Caregivers the Right Way

Why healthcare research is different

Healthcare decisions involve many people: the doctor who prescribes, the pharmacist who dispenses, the nurse who administers, the hospital that purchases, the patient who lives with the condition and the caregiver who supports them. Pharmaceutical, medical device and health-technology companies need to understand all of them.

Research with these audiences is harder than consumer research. Healthcare professionals are few, busy and frequently approached. Patients with specific conditions are a small share of the population and their information is sensitive. Regulations and industry codes add requirements that do not apply elsewhere.

A specialist healthcare panel exists to handle these challenges: a community of verified professionals and consenting patients and caregivers, profiled in enough detail that the right people can be invited to the right studies.

Who healthcare panels include

Frequent Research runs MyHealthOpinions, our healthcare panel for professionals, patients and caregivers, alongside partner panels for multi-country studies. Members are profiled by specialty, years of practice, practice setting, patient volume, and for patients, conditions they have chosen to share.

• General practitioners and family physicians
• Specialists such as cardiologists, oncologists, endocrinologists, neurologists, pulmonologists and many more
• Surgeons, anaesthetists and hospital consultants
• Nurses, pharmacists, physiotherapists and allied health professionals
• Hospital administrators, procurement heads and lab managers
• Patients living with specific conditions
• Caregivers and family members supporting patients

Verifying healthcare professionals

In healthcare research, a fake respondent does real damage. If a non-doctor answers a survey about treatment choices, the data could influence product strategy, messaging or even clinical understanding. Verification is therefore the foundation of a credible healthcare panel.

Verification typically includes checking registration details against official medical registers where available. In India, for example, doctors are registered with the National Medical Commission or state medical councils. Other checks include confirming practice details, validating contact information, telephone verification for a share of members, and consistency checks between profile data and survey answers over time.

Verification is not a one-time step. Ongoing quality scoring identifies members whose answers are inconsistent or who appear to be misrepresenting their specialty, and removes them.

Feasibility: honesty about scarce audiences

Some specialties are small. There may be only a few hundred practising specialists in a particular sub-specialty in a country, and only a fraction will be available in a given fortnight. Feasibility should be checked against real panel availability, not optimistic estimates.

Good feasibility answers four questions: how many qualifying members exist, what incidence to expect after screening, how many completes are realistic within the timeline, and what it will cost. When numbers are tight, options include extending fieldwork, broadening criteria slightly, combining online with telephone recruitment, or using qualitative research for depth where large numbers are not possible.

Common healthcare research studies

Healthcare panels support a wide range of research:

• Treatment pattern and prescribing behaviour studies
• Product and message testing with physicians
• Brand tracking among specialists
• Patient journey and unmet-needs research
• Market sizing and forecasting inputs
• Medical device usability and preference studies
• Hospital procurement and decision-process research
• Caregiver burden and support needs studies

Methods range from short online surveys to in-depth interviews, online bulletin boards and, where needed, telephone and face-to-face interviews through our offline data collection teams.

Patients and caregivers: the other half of the picture

Clinicians see a condition through diagnosis and treatment. Patients and caregivers experience it every day: symptoms, side effects, cost, travel, work, family and fear. Their perspective often reveals unmet needs that clinical research misses.

Patient research requires extra care. Questions must be sensitive and clear, consent explicit, and respondents reassured about how their information is used. Some patient groups, such as rare disease communities, are very small and closely connected, so recruitment through patient associations and careful confidentiality matter.

Caregivers are a distinct audience. Their burden, information needs and decision influence are often under-researched, and studies that include them consistently produce valuable insight.

Compliance: codes, consent and adverse events

Healthcare market research is governed by general research codes such as the ICC/ESOMAR International Code, and by sector guidelines such as those published by EphMRA for pharmaceutical market research. Core principles include transparency about the research, informed consent, protection of respondent identity, separation of research from promotion, and fair compensation.

One requirement is specific to pharma research: adverse event reporting. If a respondent mentions an adverse event, product complaint or special situation related to a client’s product during research, it may need to be reported to the client’s pharmacovigilance team within a defined timeframe. Fieldwork teams must be trained to recognise these, and the process agreed before fieldwork starts. Respondents should be told in advance that such reports may be passed on.

Honoraria and respect for time

Healthcare professionals are compensated for their time with honoraria that should reflect fair market value for their specialty and the length of the task, without being so high that they could be seen as an inducement. Patients and caregivers receive appropriate incentives too.

Respect for time matters even more than payment. Surveys for physicians should be as short as possible, relevant to their specialty and free of repetitive questions. Panels that send poorly targeted invitations quickly lose their best members.

Protecting data quality

Beyond verification, healthcare studies apply the usual quality controls: digital fingerprinting and deduplication, attention and consistency checks, removal of speeders, review of open-ended answers, and plausibility checks on clinical answers. A specialist who claims to see an impossible number of patients a week, or whose treatment choices contradict their stated specialty, is reviewed.

Our data processing & analytics team applies these checks before any data reaches the client, and reports removals transparently.

Multi-country healthcare research

Many pharma and device studies span several countries. Each market has its own healthcare system, registration bodies, honoraria norms, data-protection laws and, sometimes, language requirements. A coordinating partner manages translation, local compliance, quotas by country and specialty, and consistent quality checks across sources.

Our Sampledge platform helps manage quotas and suppliers across countries in real time, while the client keeps a single point of contact throughout.

Healthcare research in India: what to plan for

India has a large and diverse healthcare system: public hospitals, private chains, nursing homes, independent clinics and a growing digital health sector. Doctors’ practice settings, patient volumes and prescribing patterns vary sharply between metros, smaller cities and rural areas, so samples need careful quotas to reflect the market a client actually serves.

Specialists in metros are heavily surveyed and expect concise, relevant studies. Doctors in tier-2 and tier-3 cities are often under-represented in online panels and may be better reached through telephone recruitment or field teams. Language is less of an issue with HCPs, who usually work in English, but patient and caregiver research frequently needs Hindi and regional languages.

Time of year matters too. Conference seasons, festival periods and peaks of seasonal illness reduce availability. A realistic fieldwork plan accounts for these, rather than assuming every week is the same.

Qualitative healthcare research

Not every question can be answered with a survey. Why do physicians hesitate to switch patients to a new therapy? How do patients feel when they receive a diagnosis? What happens in a hospital purchasing committee? These questions need conversation.

In-depth interviews with HCPs, typically 30 to 60 minutes by video or phone, allow probing on reasoning, evidence and experience. Online bulletin boards let patients share experiences over several days at their own pace. Small group discussions work well with nurses or pharmacists. Moderators with healthcare experience and a clear understanding of compliance rules are essential, so that discussions stay focused and adverse events are recognised and handled correctly.

Qualitative and quantitative research often work best in sequence: interviews to understand the landscape and language, then a survey to measure how widespread each view is.

From data to insight in healthcare

Healthcare clients often need more than tables. Treatment-flow diagrams, patient journey maps, segmentation of physicians by attitudes and behaviour, and forecasting inputs such as patient numbers and treatment rates are typical deliverables. Analysts with healthcare experience know which comparisons are meaningful and where small bases or clinical nuance require caution.

The final report should connect findings to decisions: which specialists to prioritise, which messages resonate, which unmet needs a product could address, and what evidence physicians want to see.

Mistakes to avoid in healthcare research

Each of these can undermine a study that is otherwise well designed. Avoiding them is part of what clients should expect from a specialist healthcare research partner.

• Accepting “doctor” sample without asking how it was verified
• Writing long surveys that ignore physicians’ time
• Starting fieldwork before the adverse event process is agreed
• Over-promising specialist numbers to win a project
• Using consumer-style incentives instead of fair honoraria
• Treating patients’ health information like ordinary survey data

An example study, step by step

Imagine a medical device company that wants to understand how cardiologists in India choose between two types of devices, and what would make them try a new one. The brief calls for 150 interventional cardiologists across metros and large tier-2 cities, in three weeks.

Feasibility first: we check verified cardiologists in the panel, estimate how many perform the relevant procedures and confirm that 150 is realistic with online recruitment plus telephone support for tier-2 cities. The questionnaire is kept to about fifteen minutes, reviewed for compliance and adverse event wording, and soft-launched with a small group. During fieldwork, quotas by city tier are tracked daily, and every response is checked for plausibility. The client receives clean data, tables by segment and a short report on decision drivers, barriers and the evidence physicians want to see before switching.

Choosing a healthcare research partner

Look for transparent verification, honest feasibility, trained teams for adverse event reporting, experience with your therapy area and clear data-protection practices. Ask for the panel book, which shows specialties and counts, and ask how much of the sample comes from the partner’s own panel.

You can download our Healthcare Panel Book, read our complete market research guide, or request healthcare feasibility for your next study.

Frequently asked questions

• How do you verify that respondents are real doctors?

  We check registration details against official medical registers where available, confirm practice and contact information, telephone-verify a share of members and monitor consistency over time. Members who fail checks are removed.

• Can you reach rare specialists?

  Often, yes, but numbers may be limited. We check real availability before committing, and suggest options such as longer fieldwork, mixed recruitment methods or qualitative interviews where needed.

• How are adverse events handled during research?

  Teams are trained to recognise adverse events, product complaints and special situations. These are reported to the client’s pharmacovigilance team within the agreed timeframe, and respondents are informed of this in advance.

• Do you include patients and caregivers?

  Yes. MyHealthOpinions includes patients and caregivers who have chosen to share health information for research, with explicit consent and strict confidentiality.

• How long does a healthcare survey take to complete?

  Typical HCP online studies take one to three weeks, depending on specialty, country and sample size. Low-incidence specialists or multi-country studies may take longer.

Still curious? Ask the assistant Talk to a specialist →

Explore our Market Research services